UNSPSC 51281911: Olivomycin b

This classification denotes a dna minor groove binding agent and antineoplastic antibiotic with the molecular formula C56H80O26, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier FO0E69826C, chemically known as olivomycin d, 3d-o-(4-o-acetyl-2,6-dideoxy-3-c-methyl-.alpha.-l-arabino-hexopyranosyl)-, but more generally known as olivomycin b, which bears US NIH Compound Identifier 201840. European Medicines Agency schedules olivomycin b or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB03507MIG.

Most nations, for tariff purposes, schedule olivomycin b under HS 29419000. SMILES:.

UNSPSC 51281911 Olivomycin B is a Commodity code that represents a specialized pharmaceutical ingredient with no recent state and local procurement activity in the available record. State and local governments do not appear to be active buyers of this antibiotic compound through standard procurement channels.

Without documented recent opportunities, issuing bodies, geographic distribution, or representative solicitations to evaluate, this code does not present a current business development opportunity in state and local contracting.